Tower Research Capital (TRC)’s InMed Pharmaceuticals INM Stock Holding History

Tower Research Capital (TRC)’s Portfolio INM Stock Details INM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-400	Closed	-$1.3K	–	5408
2025 Q2	$1.3K	Buy	+400	New	+$1.11K	﹤0.01%	4831
2022 Q4	–	Sell	-53	Closed	-$7K	–	6132
2022 Q3	$7K	Buy	+53	New	+$9.8K	﹤0.01%	4891

Other funds holding INM

Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return

DRW Securities Chicago, Illinois $1.84B AUM 20.54% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Thompson Davis & Co Richmond, Virginia $150M AUM 32.35% 1-Year Est. Return

SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

AllSquare Wealth Management Albany, New York $189M AUM 14.89% 1-Year Est. Return